Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.920
+0.090 (1.86%)
At close: Nov 5, 2025, 4:00 PM EST
4.940
+0.020 (0.41%)
After-hours: Nov 5, 2025, 7:52 PM EST
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.69 billion as of November 5, 2025. Its market cap has increased by 102.34% in one year.
Market Cap
1.69B
Enterprise Value
1.20B
1-Year Change
102.34%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.69B, an increase of 866.73%. That is a compound annual growth rate of 54.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 1.66B | 84.96% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 809.63B |
| Johnson & Johnson | 450.53B |
| AbbVie | 381.47B |
| UnitedHealth Group | 302.01B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Abbott Laboratories | 218.45B |
| Novo Nordisk | 216.34B |